[144] Nuvalent, Inc. SEC Filing

Rhea-AI Filing Summary

Nuvalent, Inc. (NUVL) insider filing reports a proposed sale of 12,000 Class A Common shares through J.P. Morgan Securities on NASDAQ with an aggregate market value of $975,600. The shares were acquired and are to be sold on 09/29/2025 following a stock option exercise, with payment in cash. The filing identifies the selling person as Darlene Noci, who sold 4,000 shares on 07/30/2025 for $321,460 and 4,000 shares on 08/25/2025 for $298,494 during the prior three months. The filing also discloses 66,669,583 shares outstanding. No additional narrative, relationship to issuer, or trading-plan dates are provided in the notice.

Positive

• Full transaction detail provided: acquisition date, sale date, broker, method (stock option exercise), and aggregate market value are disclosed
• Recent sales history disclosed: two sales in prior three months with gross proceeds listed, enhancing transparency

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale following option exercise; disclosed amounts are small relative to outstanding shares and comply with Rule 144 reporting.

The filing documents a proposed sale of 12,000 shares acquired via option exercise and scheduled for sale on 09/29/2025 through J.P. Morgan Securities. Recent reported sales total 8,000 shares in the prior three months, with gross proceeds of $619,954. Against the stated 66,669,583 shares outstanding, the proposed sale represents a de minimis percentage of the float. The filing provides required transaction dates, amounts, broker details, and acquisition method, supporting market transparency.

Corporate Governance Expert

TL;DR: Disclosure is complete for Rule 144 mechanics but lacks some contextual details such as relationship to issuer or 10b5-1 plan dates.

The notice includes core Rule 144 fields: acquisition method (stock option exercise), acquisition and intended sale dates, broker identification, and recent sales history. However, the form does not specify the filer’s relationship to the issuer or indicate any Rule 10b5-1 trading plan adoption date, which are often included to clarify trading intent. Those omissions are factual gaps in the filing itself rather than additional definitive information about intent or material nonpublic facts.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	J.P. Morgan Securities LLC 390 Madison Avenue 6th Floor New York NY 10017	12000	975600	66669583	09/29/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	09/29/2025	Stock Option Exercise	Issuer			12000	09/29/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Darlene Noci One Broadway, 14th Floor Cambridge MA 02142	Common	07/30/2025	4000	321460
Darlene Noci One Broadway, 14th Floor Cambridge MA 02142	Common	08/25/2025	4000	298494

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Nuvalent (NUVL) Form 144 disclose?

The Form 144 discloses a proposed sale of 12,000 Class A Common shares with aggregate market value of $975,600, to be sold on 09/29/2025 through J.P. Morgan Securities on NASDAQ.

Who is the selling person named in the filing?

The filing names Darlene Noci as the person for whose account the securities are to be sold.

How were the shares acquired and when?

The 12,000 shares were acquired on 09/29/2025 by stock option exercise, and payment was in cash on the same date.

Were there any recent sales by the same person?

Yes. The filing reports sales of 4,000 shares on 07/30/2025 for $321,460 and 4,000 shares on 08/25/2025 for $298,494 in the past three months.

How large is the company’s share count as reported in the filing?

The Form 144 lists 66,669,583 shares outstanding.